Treatment with [166Ho]Ho-labeled polylactic acid microspheres in a patient with giant focal nodular hyperplasia

Martin-Marcuartu, J.J.; Vercher-Conejero, J.L.; Hervás-Sanz, B.; Valcarcel José, J.; Llado Garriga, L.; Cortes-Romera, M.

doi:10.1016/j.remnie.2025.500204

Revista Española de Medicina Nuclear e Imagen Molecular (English Edition)

ISSN: 2253-8089

The Revista Española de Medicina Nuclear e Imagen Molecular (Spanish Journal of Nuclear Medicine and Molecular Imaging), was founded in 1982, and is the official journal of the Spanish Society of Nuclear Medicine and Molecular Imaging.
The Journal, which publishes six regular issues per year, is committed to fostering research and advancing continuing education across all domains of Nuclear Medicine. Its main sections include Original Articles, Images of Interest, and Special Collaboration papers. Manuscripts may be submitted in either Spanish or English and are subject to a rigorous peer-review process prior to publication.

See more Open Access Option

Indexed in:

Medline

RSS

Contact

Tienda

Alert

Newsletter

Impact factor

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years.

© Clarivate Analytics, Journal Citation Reports 2025

Impact factor 2025

1.2

Citescore

CiteScore measures average citations received per document published.

Citescore 2024

0.9

SJR

SRJ is a prestige metric based on the idea that not all citations are the same. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal's impact.

SJR 2024

0.216

SNIP

SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field.

SNIP 2024

0.216

View more metrics

Journal Information

Previous article | Next article

Vol. 45. Issue 1.

(January - February 2026)

Lee este artículo en Español

Cite

Martin-Marcuartu J, Vercher-Conejero J, Hervás-Sanz B, Valcarcel José J, Llado Garriga L, Cortes-Romera M. Treatment with [166Ho]Ho-labeled polylactic acid microspheres in a patient with giant focal nodular hyperplasia. Rev Esp Med Nucl Imagen Mol. 2026;45:

Copy

Download PDF

Treatment with [166Ho]Ho-labeled polylactic acid microspheres in a patient with giant focal nodular hyperplasia

Tratamiento con microesferas de ácido poliláctico marcadas con [166Ho]Ho en paciente con hiperplasia nodular focal gigante

Visits

793

Download PDF

J.J. Martin-Marcuartua,

Corresponding author

jjmarcuartu@bellvitgehospital.cat

Corresponding author.

, J.L. Vercher-Conejeroa, B. Hervás-Sanza, J. Valcarcel Joséb, L. Llado Garrigac, M. Cortes-Romeraa

a Servicio de Medicina Nuclear - Unidad PET, Hospital Universitario de Bellvitge - IDIBELL, Barcelona, Spain

b Unidad de Radiología Intervencionista, Servicio de Radiología, Hospital Universitari de Bellvitge. Barcelona, Spain

c Unidad Cirugia HBP y Trasplante Hepático, Hospital Universitari de Bellvitge, Barcelona, Spain

This item has received

793 Visits

Article information

Full Text

Bibliography

Download PDF

Statistics

Article

These are the options to access the full texts of the publication Revista Española de Medicina Nuclear e Imagen Molecular (English Edition)

Subscriber

If you already have your login data, please click here .

If you have forgotten your password you can you can recover it by clicking here and selecting the option “I have forgotten my password”

Purchase

Purchase article

Purchasing article the PDF version will be downloaded

Purchase now

Contact

Phone for subscriptions and reporting of errors

From Monday to Friday from 9 a.m. to 6 p.m. (GMT + 1) except for the months of July and August which will be from 9 a.m. to 3 p.m.

Calls from Spain

932 415 960

Calls from outside Spain

+34 932 415 960

E-mail

atencionalcliente@elsevier.com

Treatment with [166Ho]Ho-labeled polylactic acid microspheres in a patient with giant focal nodular hyperplasia

Article

Subscribe to our newsletter